SARAH RAY: Open Payments
NPI 1417103714 · KALKASKA, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$435 in 11 payments from 9 companies in 2025. Trend: 2023 $431 · 2024 $326 · 2025 $435
Food & beverage: $435
| Company | Payments | Amount |
|---|---|---|
| Alpha Cognition USA, Inc. | 1 | $146 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $95 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $50 |
| ABBVIE INC. | 2 | $38 |
| Gilead Sciences, Inc. | 1 | $28 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| Novo Nordisk Inc | 1 | $18 |
| Lilly USA, LLC | 1 | $16 |
Products named: Zunveyl, DRIZALMA SPRINKLE, CAPLYTA, Epclusa, AUSTEDO XR, QULIPTA, FARXIGA, Ozempic.
Industry payments across MI — which companies pay providers there.
